OptimizeRx Analyst Price Targets

OptimizeRx Corp

OPRXNASDAQ

$7.86

0.212.75%

al cierre: Aug 24, 5:00 PM EST

$8.00

0.354.58%

Premercado: 4:01 AM EST

Wall Street analyst price targets and consensus rating for OptimizeRx (OPRX).

Price Target Range — 11 Quarters

Analyst Consensus — 8 Analysts

2S.Buy

5Buy

1Hold

Consensus RatingBuy# Analysts8Avg. Consensus PT$12Upside to Avg. PT+52.3%

Rating Trend — Last 9 Months

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 14, 2026	Citizens	Constantine Davides	PT Raise	Market Outperform	$9→$11
May 13, 2026	Lake Street	Eric Martinuzzi	PT Cut	Buy	$20→$11
May 13, 2026	B. Riley Securities	Anderson Schock	PT Cut	Buy	$11→$10
May 13, 2026	Stephens & Co.	Jeff Garro	PT Cut	Equal-Weight	$10→$7
May 13, 2026	Stifel	David Grossman	PT Cut	Buy	$17→$14
Mar 6, 2026	Lake Street	Eric Martinuzzi	PT Cut	Buy	$24→$20
Mar 6, 2026	Roth Capital	Richard Baldry	PT Cut	Buy	$32→$18
Mar 6, 2026	B. Riley Securities	Anderson Schock	PT Cut	Buy	$28→$11
Mar 6, 2026	Stephens & Co.	Jeff Garro	PT Cut	Equal-Weight	$17→$10
Mar 6, 2026	Stifel	David Grossman	PT Cut	Buy	$21→$17
Nov 17, 2025	Stephens & Co.	Jeff Garro	PT Cut	Equal-Weight	$20→$17
Nov 7, 2025	Citizens	Constantine Davides	PT Raise	Market Outperform	$23→$24
Oct 10, 2025	JMP Securities	Constantine Davides	PT Raise	Market Outperform	$20→$23
Aug 11, 2025	JMP Securities	Constantine Davides	PT Raise	Market Outperform	$14→$20
Aug 8, 2025	Stifel	David Grossman	PT Raise	Buy	$16→$18
Jun 9, 2025	Stifel	David Grossman	PT Raise	Buy	$13→$16
May 13, 2025	Stifel	David Grossman	PT Raise	Buy	$8→$13
May 13, 2025	JMP Securities	Constantine Davides	PT Raise	Market Outperform	$11→$14
Feb 6, 2025	JMP Securities	Constantine Davides	Maintained	Market Outperform	$8
Jan 8, 2025	RBC Capital	Sean Dodge	Downgrade	Outperform→Sector Perform	$7→$6